India Biologics Market Analysis: Emerging Technologies and Forecast
The India Biologics Market is expected to benefit from continued expansion of biopharmaceutical manufacturing infrastructure. Mammalian cell cultures currently represent the largest source segment, accounting for about 62% of the market, while microbial sources are identified as the fastest-growing category. Hospitals represent the largest end-user segment, holding approximately 52% of the...
0 Comments 0 Shares 43 Views 0 Reviews